Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.
Baker
G M
GM
Department of Pharmacy, University of Cincinnati Medical Center, Ohio 45267-0740, USA.
Martin
J E
JE
Jang
R
R
Schroeder
T J
TJ
Armitstead
J A
JA
Myre
S
S
First
M R
MR
D001379:Azathioprine / Q000191:economics* / Q000627:therapeutic use; D002102:Cadaver; D003365:Costs and Cost Analysis; D006084:Graft Rejection / Q000191:economics* / Q000276:immunology / Q000517:prevention & control; D006785:Hospitals, University; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000191:economics* / Q000276:immunology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D009820:Ohio; D011183:Postoperative Complications / Q000191:economics; D014019:Tissue Donors
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D001379:Azathioprine